Top 5 theatre shows to see this week (October 1-7)
Mrs Dalloway – Arcola Theatre, London
Having set the world on fire in Morgan Lloyd Malcolm’s Emilia at Shakespeare’s Globe, Clare Perkins plays the title role in Thomas Bailey’s production of the novel by Virginia Woolf. It opens on October 1.
Sketching – Wilton’s Music Hall, London
Experiment in multi-authored playwriting from James Graham and director Thomas Hescott, written in collaboration with eight emerging writers following an open application process seeking voices currently underrepresented in the industry. It opens at Wilton’s Music Hall on October 2.
A Midsummer Night’s Dream – Crucible Theatre, Sheffield
Pandora Colin and Sophia Nomvete star in the Crucible’s annual big autumn Shakespeare production directed by Robert Hastie with music by Dan ‘Everybody’s Talking About Jamie’ Gillespie Sells. It opens on October 2.
Future Bodies – Home, Manchester
Unlimited Theatre and RashDash join forces for a new piece that explores human enhancement technologies. Working with prominent scientists in the field, Future Bodies imagines the impact on humanity of a world of neurological implants and smart drugs. It opens on October 3.
The Sweet Science of Bruising – Southwark Playhouse, London
This new play by Joy Wilkinson – one of the writers of the upcoming season of Doctor Who – is set in the world of Victorian women’s boxing. Directed by Kirsty Patrick Ward, it opens at Southwark Playhouse on October 5.
We need your help…
When you subscribe to The Stage, you’re investing in our journalism. And our journalism is invested in supporting theatre and the performing arts.
The Stage is a family business, operated by the same family since we were founded in 1880. We do not receive government funding. We are not owned by a large corporation. Our editorial is not dictated by ticket sales.
We are fully independent, but this means we rely on revenue from readers to survive.
Help us continue to report on great work across the UK, champion new talent and keep up our investigative journalism that holds the powerful to account. Your subscription helps ensure our journalism can continue.